These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18990924)

  • 1. Loss of confidence in diabetes management.
    Salber PR; Bestermann W; Schwartz S; Marchetti A
    Manag Care; 2008 Oct; 17(10):38-46. PubMed ID: 18990924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive treatment of type 2 diabetes: a managed care consensus statement.
    Manag Care Interface; 2003; Suppl A():14-8. PubMed ID: 12564407
    [No Abstract]   [Full Text] [Related]  

  • 3. Can amylin analogue lead to better diabetes control?
    Morrow T
    Manag Care; 2003 Dec; 12(12):40-1. PubMed ID: 14723102
    [No Abstract]   [Full Text] [Related]  

  • 4. Overcoming obstacles to effective care of type 2 diabetes.
    Kogan AJ
    Am J Manag Care; 2009 Sep; 15(9 Suppl):S255-62. PubMed ID: 19817514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
    Nadeau DA
    Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.
    Collins FM
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S460-71. PubMed ID: 12408409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic management of the patient with type 2 diabetes.
    Quinn L
    Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care.
    Killilea T
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S441-9. PubMed ID: 12408407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient management strategies in type 2 diabetes: current practices and future considerations.
    Blonde L
    J Manag Care Pharm; 2005 Aug; 11(6 Suppl B):S12-8. PubMed ID: 23570225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving care for patients with type 2 diabetes: applying management guidelines and algorithms, and a review of new evidence for incretin agents and lifestyle intervention.
    Blonde L
    Am J Manag Care; 2011 Nov; 17 Suppl 14():S368-76. PubMed ID: 22214424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinician's view of the role of insulin and why it should be better used.
    Manag Care Interface; 2003; Suppl C():15-7. PubMed ID: 14569632
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New technologies and therapies in the management of diabetes.
    Triplitt CL
    Am J Manag Care; 2007 Apr; 13 Suppl 2():S47-54. PubMed ID: 17417933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving glycemic goals in type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 2007 Jan; 30(1):174-80. PubMed ID: 17192357
    [No Abstract]   [Full Text] [Related]  

  • 17. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of diabetes care in the United States.
    Blonde L
    Am J Manag Care; 2007 Apr; 13 Suppl 2():S36-40. PubMed ID: 17417931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient empowerment and optimal glycemic control.
    White RD
    Curr Med Res Opin; 2012 Jun; 28(6):979-89. PubMed ID: 22429065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic options in the treatment of diabetes mellitus.
    Miller CK
    Pharm Pract Manag Q; 1997 Oct; 17(3):10-20. PubMed ID: 10173307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.